Article info
Commentary
Inhibition of monoacylglycerol lipase for the treatment of liver disease: tempting but still playing with fire
- Correspondence to Professor Claus Hellerbrand, Institute of Biochemistry (Emil-Fischer Zentrum), Friedrich-Alexander University Erlangen-Nürnberg, Erlangen D-91054, Germany; claus.hellerbrand{at}fau.de
Citation
Inhibition of monoacylglycerol lipase for the treatment of liver disease: tempting but still playing with fire
Publication history
- Received October 17, 2018
- Revised October 23, 2018
- Accepted October 23, 2018
- First published November 15, 2018.
Online issue publication
February 07, 2019
Article Versions
- Previous version (15 November 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.